News / Health

Synthetic Malaria Drug Made Through Biotech, Yeast

A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
Jessica Berman
The World Health Organization says more than 200 million people - mostly in sub-Saharan Africa - were infected with malaria in 2010.  The mosquito-borne parasitic illness annually kills 650,000 people, a majority of them young children.

The most effective anti-malaria treatment developed so far is artemisinin, a plant-derived drug that is expensive and often unavailable.  Now, after a decade-long research effort, scientists have found a novel way to cheaply mass-produce artemisinin. The new, bio-synthetic version of the drug could be a major advance in the battle against malaria.

Whenever he travels to Africa, Jack Newman says he arrives prepared with his own supply of artemisinin.

“I always keep it in my back pocket in case I get malaria," said Newman. "Again, in three days you are cured.”

The American researcher hopes others infected with the parasitic illness might soon have easy access to the drug, too.

Newman is co-founder of Amyris, a U.S. biotechnology company that, in collaboration with researchers at the University of California Berkeley and the Canadian National Research Council, developed a process for making large quantities of a semi-synthetic version of artemisinin, offering people with uncomplicated malaria a cure in just three days.  

Artemisinin is a compound that until now has been derived exclusively from an ancient, bitter herb called wormwood.  It is up to 95 percent effective in curing uncomplicated malaria infections but, because it is derived from a plant, artemisinin is frequently in short supply, and expensive.

Newman and his colleagues figured out a way to make an unlimited supply of artemisinin using a technique that combines biotechnology and a simple yeast fermentation process.  

He says they extracted DNA from the wormwood plant and inserted it into yeast cells …

“..to fire up a big fermentation, like beer fermentation, but instead of making beer, you are actually making [an] anti-malarial drug," he said. "And you can do it in hundreds of thousands of gallons and, of course, make it in an industrial fashion, the same way we make penicillin;  very, very inexpensively.”

The process yields a chemical precursor to artemisinin, which is used in the production of the drug.

The innovation was made possible in large part by grants totaling $53.3 million from the Bill and Melinda Gates Foundation to the drug development arm of PATH, an international non-profit group that has been leading the fight against malaria and other diseases.  PATH helped move the artemisinin research out of the UC Berkeley labs to Amyris for scale-up, and then to the pharmaceutical company Sanofi Pasteur, for production of the yeast-based artemisinin. The company says it is distributing the drug free of charge.

Sanofi also plans to share the recipe with other drug makers so they, too, can use the technology to manufacture and distribute it on a “no profit, no loss” basis, according to Amyris's Jack Newman.

“Basically, by using synthetic biology, we’ve been able to stabilize the production so there’s always material available and make it at a very low cost," he said.

Newman says the yeast-based drug is identical to plant-derived artemisinin in terms of effectiveness. It is being formulated with a second anti-malaria compound to reduce the chances of drug resistance.

So far, Newman says, Sanofi plans to make 70 million doses of what he calls malaria “cures” this year. Using synthetic biology, next year the company will scale up production to 120 million doses, which will be distributed globally pending World Health Organization approval.

Jack Newman and his colleagues describe their production of a semi-synthetic version of the anti-malarial drug artemisinin in an article published in the journal Nature.  

You May Like

Karzai's Legacy: Missed Opportunities?

Afghanistan's president leaves behind a much different nation than the one he inherited, yet his legacy from 13 years in power is getting mixed reviews More

Video Secret Service Chief Under Fire for White House Security Breach

Julia Pierson faces tough questions from lawmakers after recent intrusion at White House, says: 'It is clear that our security plan was not executed properly' More

Frustrated, Liberian Students Want Ebola Fight Role

Thousands have volunteered to go to counties, rural villages to talk to people in their language about deadly virus More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
The Legacy of Jimmy Carter: The Preacher from Plainsi
X
October 01, 2014 10:45 AM
It is common in the United States to see tourists flock to sites associated with America's presidents. Some are privately owned and others are run by the National Park Service or the National Archives -- but most have helped draw business and people into the towns and cities where they are located. As VOA’s Kane Farabaugh reports, there is one particular presidential hometown that is unique in what it has to offer those who make the trip.
Video

Video The Legacy of Jimmy Carter: The Preacher from Plains

It is common in the United States to see tourists flock to sites associated with America's presidents. Some are privately owned and others are run by the National Park Service or the National Archives -- but most have helped draw business and people into the towns and cities where they are located. As VOA’s Kane Farabaugh reports, there is one particular presidential hometown that is unique in what it has to offer those who make the trip.
Video

Video Hong Kong Protests Draw New Supporters on National Holiday

On the 65th anniversary of the founding of Communist China, Hong Kong protesters are hoping to stage the largest pro-democracy demonstration since the 1989 Tiananmen protests. VOA's Brian Padden visited one of the protest sites mid-day, when the atmosphere was calm and where the supporters were enthusiastic about joining what they are calling the umbrella revolution.
Video

Video India's PM Continues First US Visit

India's prime minister is on his first visit to Washington, to strengthen political and economic ties between the world's oldest and the world biggest democracies. He came to the U.S. capital from New York, the first stop on his five-day visit to the country that denied him an entry visa in the past. From Washington, Zlatica Hoke reports Modi seemed most focused on attracting foreign investment and trade to increase job opportunities for his people.
Video

Video Malaysia Struggles to Stop People Joining Jihad

Malaysian authorities say militant groups like the so-called "Islamic State" have used social media to entice at least three dozen Malaysian Muslims to fight in what they call "jihad" in Syria and Iraq. As Mahi Ramkrishnan reports from Kuala Lumpur, counterterrorism police are deeply worried about what could happen when these militants return home.
Video

Video Could US Have Done More to Stop Rise of Islamic State?

President Obama says airstrikes against Islamic State militants in Syria will likely continue for some time because, in his words, "there is a cancer that has grown for too long." So what if President Obama had acted sooner in Syria to arm more-moderate opponents of both the Islamic State and the Syrian government? VOA State Department Correspondent Scott Stearns reports from the United Nations.
Video

Video Treasure Hunters Seek 'Hidden Treasure' in Central Kenya

Could a cave in a small village in central Kenya be the site of buried treasure? A rumor of riches, left behind by colonialists, has some residents dreaming of wealth, while others see it as a dangerous hoax. VOA's Gabe Joselow has the story.
Video

Video Ebola Patients Find No Treatment at Sierra Leone Holding Center

At a holding facility in Makeni, central Sierra Leone, dozens of sick people sit on the floor in an empty university building. They wait in filthy conditions. It's a 16-hour drive by ambulance to Kailahun Ebola treatment center. Adam Bailes was there and reports on what he says are some of the worst situations he has seen since the beginning of this Ebola outbreak. And he says it appears case numbers may already be far worse than authorities acknowledge.
Video

Video Identifying Bodies Found in Texas Border Region

Thousands of immigrants have died after crossing the border from Mexico into remote areas of the southwestern United States in recent years. Local officials in south Texas alone have found hundreds of unidentified bodies and buried them in mass graves in local cemeteries. Now an anthropologist and her students at Baylor University have been exhuming bodies and looking for clues to identify them. VOA’s Greg Flakus has more from Waco, Texas.
Colonel Steve ‘Spiros’ Pisanos left Greece and came to the U.S. to learn to fly. He flew fighters for the Allies in World War II, narrowly escaping death multiple times.Colonel Steve ‘Spiros’ Pisanos left Greece and came to the U.S. to learn to fly. He flew fighters for the Allies in World War II, narrowly escaping death multiple times.

AppleAndroid